The Prevalence of Asymptomatic Bacteriuria in Iranian Pregnant Women: A Systematic Review and Meta-Analysis

Ghafari, Mahin; Baigi, Vali; Cheraghi, Zahra; Doosti-Irani, Amin

doi:10.1371/journal.pone.0158031

Cited by 27 publications

(30 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In this study prevalence of ASB was 14.2% (95% CI, 10.98% to 19.22%). This prevalence was above the general range of 2% to 10% but fits in the range from 1.9% to 15% being reported [20]. The prevalence in this study was close to 13.2% found in Mangalore, Karnataka in India [21].…”

Section: Discussionsupporting

confidence: 76%

“…Therefore ASB prevalence differs from setting to setting. E. coli is the most common isolate in ASB as it was also confirmed in a prospective study in Odisha state, India and in Abuja (56.%) [19][20][21][22][23]. CoNS is one of isolated uropathogens [25].…”

Section: Discussionmentioning

confidence: 63%

“…The bacteria were more susceptible to gentamycin, ceftriaxone and ciprofloxacin but resistant to nitrofurantoin and ampicillin. Nitrofurantoin is a widely recommended antibiotic for ASB treatment in pregnancy and it is associated with 80% cure rate with a 5 to 7 day course [15][16][17][18][19][20][21][22][23][24][25][26][27][28][29]. Suggested first line treatment include amoxil, nitrofurantoin and oral cephalosporins and gentamycin and ceftriaxone for staphylococcus and pseudomonas [30,31].…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Untitled

2017

MOJI

View full text Add to dashboard Cite

Background and objective: Effective treatment of asymptomatic bacteriuria in pregnancy requires susceptible drugs. The aim of this study was to determine antibiotic susceptibility pattern among isolated bacterial species among pregnant women with asymptomatic bacteriuria. Materials and Methods:This study was conducted at 4 selected primary health care facilities in Harare, including pregnant women registering for antenatal care at gestation between 6 and 22 weeks and without urinary tract infection symptoms. Asymptomatic bacteriuria was diagnosed by culture test of all midstream urine samples following screening by Griess nitrate test. Susceptibility test was done for all positive 24 hour old culture using the disk diffusion test. The minimum inhibitory concentration was measured and categorized as susceptible, resistant and intermediate.

show abstract

Section: Discussionsupporting

confidence: 76%

Section: Discussionmentioning

confidence: 63%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Untitled

2017

MOJI

View full text Add to dashboard Cite

show abstract

“…3 Several physiological, immunological and anatomical changes that occur during the pregnancy as well as the other risk factors like age, parity, personal hygiene and sexual activity predispose the women to develop ASB and are well described in literature. [3][4][5][6] Prevalence of ASB in pregnant women is thought to be about 2-11%. 4,7,8 ASB in pregnancy poses a high risk for low birth weight, preterm deliveries, acute pyelonephritis and acute cystitis.…”

Section: Introductionmentioning

confidence: 99%

“…[3][4][5][6] Prevalence of ASB in pregnant women is thought to be about 2-11%. 4,7,8 ASB in pregnancy poses a high risk for low birth weight, preterm deliveries, acute pyelonephritis and acute cystitis. 9,10 These cases account for 70% of all cases of symptomatic urinary tract infections (UTI) among unscreened pregnant women.…”

Section: Introductionmentioning

confidence: 99%

A cross-sectional study on asymptomatic bacteriuria among antenatal women attending an urban tertiary health care center in Southern India

Paari¹,

Sindhuja²,

Dhinakaran³

et al. 2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: Asymptomatic bacteriuria (ASB) in pregnancy is a treatable risk factor for preterm delivery. India accounts for the highest preterm birth incidence in the world according to the WHO census released in November 2016. This study was aimed at finding the prevalence of asymptomatic bacteriuria, the spectrum of bacteria involved and the susceptibility pattern for the antimicrobials in the antenatal women attending a tertiary care hospital in urban Southern India.Methods: One hundred and eighty ante-natal patients without symptoms of ongoing urinary tract infection were enrolled to this study. Clean midstream urine sample was collected in a wide mouthed container and sample was analyzed by standardized microbiological testing techniques.Results: Out of the 180 ante-natal women included in the study, 11(6.1%) patients were found to have insignificant bacteriuria and 38(21.1%) had a significant bacteriuria. E. coli was the most frequently isolated organism and about 95% of the organisms were sensitive to Nitrofurantoin.Conclusions: More than a fifth of all pregnant women have ASB and E. coli is the most frequent pathogen encountered.

show abstract

Bacterial profile and antimicrobial resistance patterns of common bacteria among pregnant women with bacteriuria in Ethiopia: a systematic review and meta-analysis

Chelkeba

Fanta

Mulugeta

et al. 2022

Arch Gynecol Obstet

View full text Add to dashboard Cite

Background Globally, antimicrobial resistance (AMR) restricted the armamentarium of the health care providers against infectious diseases, mainly due to the emergence of multidrug resistant. This review is aimed at providing contemporary bacterial profile and antimicrobial resistance pattern among pregnant women with significant bacteriuria. Methods Electronic biomedical databases and indexing services such as PubMed/MEDLINE, Web of Science, EMBASE and Google Scholar were searched. Original records of research articles, available online from 2008 to 2021, addressing the prevalence of significant bacteriuria and AMR pattern among pregnant women and written in English were identified and screened. The relevant data were extracted from included studies using a format prepared in Microsoft Excel and exported to STATA 14.0 software for the outcome measure analyses and subgrouping. Results The data of 5894 urine samples from 20 included studies conducted in 8 regions of the country were pooled. The overall pooled estimate of bacteriuria was 15% (95% CI 13–17%, I2 = 77.94%, p < 0.001) with substantial heterogeneity. The pooled estimate of Escherichia coli recovered from isolates of 896 urine samples was 41% (95% CI 38–45%) followed by coagulase-negative Staphylococci, 22% (95% CI 18–26%), Staphylococcus aureus, 15% (95% CI 12–18%), Staphylococcus saprophytic, 12% (95% CI 6–18%) Proteus mirabilis, 7% (95% CI 4–10%), Enterococcus species, 6% (0–12%), Pseudomonas aeruginosa, 4% (2–6%), Citrobacter species, 4% (95% CI 2–4%), Group B streptococcus, 3% (1–5%), and Enterobacter species, 2% (1–4%). Multidrug resistance proportions of E. coli, Klebsiella species, Staphylococcus aureus and Coagulase negative staphylococci, 83% (95% CI 76–91%), 78% (95% CI 66–90%), 89% (95% CI 83–96%), and 78% (95% CI 67–88%), respectively. Conclusion The result of current review revealed the occurrence of substantial bacteriuria among pregnant women in Ethiopia. Resistance among common bacteria (E. coli, Klebsiella species, Staphylococci species) causing UTIs in pregnant women is widespread to commonly used antibiotics. The high rate of drug resistance in turn warrants the need for regular epidemiological surveillance of antibiotic resistance and implementation of an efficient infection control and stewardship program.

show abstract

The Prevalence of Asymptomatic Bacteriuria in Iranian Pregnant Women: A Systematic Review and Meta-Analysis

Cited by 27 publications

References 18 publications

Untitled

Untitled

A cross-sectional study on asymptomatic bacteriuria among antenatal women attending an urban tertiary health care center in Southern India

Bacterial profile and antimicrobial resistance patterns of common bacteria among pregnant women with bacteriuria in Ethiopia: a systematic review and meta-analysis

Contact Info

Product

Resources

About